Universal Health International Group Holding Ltd. stock analysis
Want to see HK:2211 full AI Analyst Report?
Universal Health International Group Holding Ltd. (2211) Stock Price & Analysis
2211 Stock Chart & Stats
- Day’s Range
- HKD 0.47 - HKD 0.60
- 52-Week Range
- HKD 0.31 - HKD 4.05
- Previous Close
- HKD 0.48
- Volume
- N/A
- Average Volume (3M)
- 669.43K
- Market Cap
- HKD 315.06M
- Enterprise Value
- HKD 36.74M
- Total Cash (Recent Filing)
- HKD 58.87M
- Total Debt (Recent Filing)
- HKD 47.14M
- Price to Earnings (P/E)
- ―
- Beta
- 1.26
- Next Earnings
- Feb 25, 2027 (Est.)
- EPS Estimate
- N/A
- Last Dividend Ex-Date
- Sep 17, 2015
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Low Leverage / Balance-sheet Flexibility
A very low debt-to-equity (~0.08) provides durable financial flexibility: it reduces near-term default risk, preserves borrowing capacity, and gives management time to execute recovery plans or raise capital without immediate solvency pressure, supporting viability over months.
Improved Gross Margins
Material gross margin improvement from prior weak levels indicates better unit economics and cost control at the production or product level. If revenue stabilizes, higher gross margins create a clearer path to sustained operating leverage and eventual profitability over the medium term.
Historical Near-breakeven Year
A roughly breakeven operating result in FY2024 shows the business can, under certain conditions, reach near-profitability. This suggests structural cost bases and operational levers exist that management can reapply to pursue a durable recovery if revenue trends reverse.
Bears Say
Shrinking Revenue
A multi-year revenue decline (≈24% in FY2025 following FY2024 drops) is a structural headwind: it reduces scale, undermines pricing power, and prevents fixed-cost absorption. Without sustained top-line stabilization, margin gains won’t convert into durable profitability.
Persistent Negative Cash Generation
Consistently negative operating and free cash flow means the business is not self-funding; this creates ongoing reliance on external financing or asset draws. Over months, continuous burn pressures liquidity, limits reinvestment, and raises execution risk for recovery plans.
Inconsistent Profitability And Equity Erosion
Negative ROE and declining equity reflect cumulative losses and capital erosion, which reduce financial resilience. Over the medium term this impairs the company’s ability to absorb shocks, invest in growth, and deliver shareholder returns without external recapitalization.
Universal Health International Group Holding Ltd. News
Universal Health Sets December AGM to Approve Accounts, Board Changes and Share Mandate
Universal Health International Group Holding Ltd. ( ($HK:2211) ) has shared an announcement. Universal Health International Group Holding Ltd., a Cayman-incorporated healthcare group listed in Hong Kong, runs its operations
Universal Health International Narrows Operating Loss Amid Revenue Decline
Universal Health International Group Holding Ltd. ( ($HK:2211) ) has shared an update. Universal Health International Group Holding Ltd., a Cayman Islands-incorporated healthcare group listed in Hong Kong, reported a
Universal Health Confirms Effective Date for Capital Reorganisation and Share Certificate Exchange
An announcement from Universal Health International Group Holding Ltd. ( ($HK:2211) ) is now available. Universal Health International Group Holding Ltd. has confirmed that its previously approved capital reorganisation will
Universal Health International Shifts Cayman Islands Registered Office and Registrar
Universal Health International Group Holding Ltd. ( ($HK:2211) ) has provided an update. Universal Health International Group Holding Ltd. has changed its registered office and principal share registrar and transfer
Universal Health Wins Shareholder Backing for Capital Reorganisation and Rights Issue
The latest update is out from Universal Health International Group Holding Ltd. ( ($HK:2211) ). Universal Health International Group Holding Ltd. obtained shareholder approval at its 15 September 2026 extraordinary
Universal Health Revises Timetable for Capital Reorganisation and Rights Issue
Universal Health International Group Holding Ltd. ( ($HK:2211) ) has shared an announcement. Universal Health International Group Holding Ltd., a Cayman Islands-incorporated healthcare company listed on the Hong Kong Stock
2211 FAQ
What was Universal Health International Group Holding Ltd.’s price range in the past 12 months?
What is Universal Health International Group Holding Ltd.’s market cap?
When is Universal Health International Group Holding Ltd.’s upcoming earnings report date?
How were Universal Health International Group Holding Ltd.’s earnings last quarter?
Is Universal Health International Group Holding Ltd. overvalued?
Does Universal Health International Group Holding Ltd. pay dividends?
What is Universal Health International Group Holding Ltd.’s EPS estimate?
How many shares outstanding does Universal Health International Group Holding Ltd. have?
What happened to Universal Health International Group Holding Ltd.’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Universal Health International Group Holding Ltd.?
What is the TipRanks Smart Score and how is it calculated?
Universal Health International Group Holding Ltd. Stock Smart Score
Company Description
Universal Health International Group Holding Ltd.
Operating as an investment holding company, Universal Health International Group Holding Limited specializes in the wholesale, retail, and distribution of a comprehensive range of pharmaceutical and healthcare products across China's northeastern region. Its extensive offerings span both Western and traditional Chinese medicines, including patent medicines, chemical preparations, antibiotics, biochemical and biological drugs, traditional Chinese medicine decoction pieces, protein assimilation preparations, peptide hormones, and blood products. The company also supplies medical equipment, disinfection products, nutritional and prepackaged foods, health care items, cosmetics, daily necessities, and specific consumer goods such as family planning supplies (e.g., contraceptives) and infant formula milk powder. Furthermore, Universal Health International Group Holding Limited provides storage services to its varied clientele, which includes pharmaceutical retailers, hospitals, clinics, and distributors. Founded in 1998, the enterprise was formerly known as Jintian Pharmaceutical Group Limited until its rebranding in July 2015, and its corporate headquarters are located in Shenyang, People's Republic of China.
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- CEO
- Chuanfu Chu
- Employees
- 601
- Website
- www.uhighl.com
- Address
- No. 14-1, Bei Yi Zhong Road, Shenyang, LI, 110000, CN
Universal Health International Group Holding Ltd. (2211) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 13 | 4 | 5 |
| Technical Analysis | 2 | 4 | 4 |
| Moving Averages | 11 | 0 | 1 |









